Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.